Osimertinib, also known by the brand name Tagrisso, is a targeted therapy drug that is used to treat non-small cell lung cancer (NSCLC) that has spread to other parts of the body (metastatic). It is most commonly used to treat NSCLC that has a specific type of gene mutation called an epidermal growth factor receptor (EGFR) mutation. Osimertinib is a type of tyrosine kinase inhibitor, which means that it works by blocking the action of a protein called EGFR. EGFR is a protein that helps cancer cells grow and divide. By blocking EGFR, osimertinib can help to slow the growth of cancer cells and may even kill them.
Osimertinib has been shown to be effective in treating NSCLC with EGFR mutations. In clinical trials, osimertinib has been shown to prolong the lives of people with NSCLC with EGFR mutations. It has also been shown to improve the quality of life for people with this type of cancer.
Osimertinib is not without side effects. The most common side effects of osimertinib are diarrhea, nausea, vomiting, and fatigue. Other side effects can include skin rash, dry eyes, and muscle pain. In some cases, osimertinib can cause more serious side effects, such as heart problems, liver problems, and lung problems.
If you are considering treatment with osimertinib, it is important to talk to your doctor about the risks and benefits of this drug. Osimertinib may be a good option for you if you have NSCLC with an EGFR mutation and you are looking for a treatment that can help to prolong your life and improve your quality of life.
Here are some additional information about Osimertinib:
Osimertinib is a pill that is taken once a day.
Osimertinib is usually used for people with NSCLC that has spread to other parts of the body (metastatic).
Osimertinib can also be used for people with NSCLC that has not spread to other parts of the body (locally advanced) if they have a specific type of EGFR mutation.
Osimertinib is not a cure for NSCLC.
Osimertinib can cause side effects, some of which can be serious.
If you are considering treatment with osimertinib, it is important to talk to your doctor about the risks and benefits of this drug.